Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology

Molecular Therapy - United States
doi 10.1038/mt.2016.85
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Characterization of a Prostate- And Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

Development of a Nanotechnology Platform for Prostate Cancer Gene Therapy

2011English

Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene in Prostate Cancer Using Liposomal Nanotechnology

2011English

Nanotechnology in Cancer Therapeutics: Bioconjugated Nanoparticles for Drug Delivery

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Delivery of Anti-miRNA for Triple Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting to Stem Cell Marker CD133

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Two Prostate Cancer‑associated Polymorphisms in the 3'UTR of IGF1R Influences Prostate Cancer Susceptibility by Affecting miRNA Binding

Oncology Reports
MedicineCancer ResearchOncology
2018English

Pro PSA: A More Cancer Specific Form of Prostate Specific Antigen for the Early Detection of Prostate Cancer.

Keio Journal of Medicine
Medicine
2003English

Retraction Note To: Identification of Core miRNA Based on Small RNA-seq and RNA-seq for Colorectal Cancer by Bioinformatics

Tumor Biology
MedicineCancer Research
2015English

miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy